# Lamotrigine

## Lamictal 50mg

| TAH Drug Code      | [OLAMC](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OLAMC)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Monotherapy in adult and children >12 year or as add-on therapy in adult and children > 2 year for the treatment of epilepsy (partial seizures and generalised seizures), including tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome. Prevention of depressive episodes in patients with bipolar disorder.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | Adult & childn > 12yrs for mono therapy: Initially 25 mg once a day for 2 weeks, and 50 mg once a day for next 2 weeks, then increasing up to 50-100 mg every 1-2 weeks to achieve the desired effect. Maitenance: 100-500 mg/day in 1-2 divided doses. With valproate or without other antiepileptic drugs: the initial dose of Lamictal is 25 mg every other day for 2 weeks; then 25 mg daily for the next 2 weeks. Then increase 25-50 mg at most every 1-2 weeks to achieve an appropriate response. Maintenance: 100-200 mg/day QD or BID. With other Antiepileptic drugs or other drugs that induce lamotrigine aldose: Initially 50 mg QD for 2weeks, and 100 mg BID for the next 2 weeks. then increasing to 100 mg every 1-2 weeks to achieve the desired effect. Maintenance: 200-700 mg/day in 1-2 divided doses. With other drugs that do not significantly inhibit or induce lamotrigine aldose: Initially 25 mg QD for 2weeks, and 50 mg BID for the next 2 weeks. then increasing to 50-100 mg every 1-2 weeks to achieve the desired effect. Maintenance: 100-200 mg/day in 1-2 divided doses.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Hypersensitivity to any component of the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Adverse Effects    | Skin rash, irritability, headache, drowsiness, insomnia, dizziness, tremor, nystagmus, ataxia, diplopia, blurred vision, nausea, vomiting, diarrhoea, tiredness, arthralgia, pain, back pain. Dermatologic: Rash (immediate-release, 10% or less (adult); 14% (pediatric) ) Gastrointestinal: Abdominal pain (immediate-release, 5% to 10% ), Diarrhea (immediate-release, 6% to 11%; extended-release, 5% ), Indigestion (immediate-release, 2% to 7% ), Nausea (immediate-release, 7% to 25%; extended-release, 7% ), Vomiting (immediate-release, 5% to 20%; extended-release, 6%)) Neurologic: Asthenia (immediate-release, 2% to 8%; extended-release, 6% ), Ataxia (immediate-release, 2% to 11% ), Coordination problem (immediate-release, 6% to 7%; extended-release, 3% ), Dizziness (immediate-release, 7% to 54% ; extended release, 14% ), Headache (immediate-release, 29% ), Insomnia (immediate-release, 5% to 10% ), Somnolence (immediate-release, 9% to 17%; extended-release, 5% ), Tremor (immediate-release, 4% to 10%; extended-release, 6% ), Vertigo (immediate-release, 2%; extended-release, 3% ) Ophthalmic: Blurred vision (immediate-release, 11% to 25% (adults) and 4% (children); extended-release, 3%), Diplopia (immediate-release, 24% to 49% (adults) and 5% (children); extended-release, 5%) Psychiatric: Anxiety (immediate-release, 4%; extended-release, 3%), Depression (immediate-release, 4%; extended-release, 3% ) Reproductive: Dysmenorrhea (immediate-release, 5% to 7% ) Respiratory: Rhinitis (immediate-release, 7% to 14% ) Other: Pain (immediate-release, 5%) |
| Pregnancy          | Compatible â€“ Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

